SG Americas Securities LLC cut its stake in shares of Catalent, Inc. (NYSE:CTLT) by 9.2% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 38,405 shares of the company’s stock after selling 3,905 shares during the period. SG Americas Securities LLC’s holdings in Catalent were worth $1,533,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Teachers Advisors LLC increased its position in Catalent by 5.0% during the first quarter. Teachers Advisors LLC now owns 173,062 shares of the company’s stock worth $4,901,000 after acquiring an additional 8,314 shares during the period. Capstone Asset Management Co. increased its holdings in Catalent by 2.3% in the 2nd quarter. Capstone Asset Management Co. now owns 10,130 shares of the company’s stock valued at $356,000 after buying an additional 230 shares during the period. Bank of Montreal Can increased its holdings in Catalent by 7,372.1% in the 2nd quarter. Bank of Montreal Can now owns 82,716 shares of the company’s stock valued at $2,903,000 after buying an additional 81,609 shares during the period. LS Investment Advisors LLC increased its holdings in Catalent by 15.7% in the 2nd quarter. LS Investment Advisors LLC now owns 10,303 shares of the company’s stock valued at $362,000 after buying an additional 1,398 shares during the period. Finally, Aperio Group LLC grew its holdings in shares of Catalent by 0.8% in the 2nd quarter. Aperio Group LLC now owns 23,088 shares of the company’s stock worth $810,000 after purchasing an additional 190 shares during the last quarter. 99.49% of the stock is currently owned by hedge funds and other institutional investors.
CTLT has been the topic of several analyst reports. BidaskClub raised shares of Catalent from a “sell” rating to a “hold” rating in a report on Wednesday, August 16th. Zacks Investment Research downgraded shares of Catalent from a “buy” rating to a “hold” rating in a research report on Friday, August 18th. Piper Jaffray Companies restated a “buy” rating and set a $45.00 target price on shares of Catalent in a research report on Tuesday, August 29th. J P Morgan Chase & Co reiterated a “buy” rating and issued a $40.00 price target on shares of Catalent in a research report on Tuesday, August 29th. Finally, Jefferies Group reissued a “hold” rating and issued a $38.00 target price (up from $35.00) on shares of Catalent in a research note on Tuesday, August 29th. Four investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Catalent currently has a consensus rating of “Buy” and a consensus price target of $44.25.
Shares of Catalent, Inc. (CTLT) traded up $1.18 during trading hours on Thursday, hitting $39.23. The stock had a trading volume of 1,127,100 shares, compared to its average volume of 911,957. The company has a debt-to-equity ratio of 2.01, a current ratio of 2.91 and a quick ratio of 2.49. Catalent, Inc. has a one year low of $23.09 and a one year high of $43.39. The firm has a market capitalization of $5,055.30, a price-to-earnings ratio of 26.61, a price-to-earnings-growth ratio of 2.45 and a beta of 1.41.
Catalent (NYSE:CTLT) last announced its quarterly earnings results on Monday, November 6th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.20 by $0.01. The business had revenue of $543.90 million during the quarter, compared to the consensus estimate of $490.75 million. Catalent had a return on equity of 23.97% and a net margin of 5.01%. Catalent’s revenue was up 23.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.16 earnings per share. research analysts anticipate that Catalent, Inc. will post 1.46 EPS for the current year.
In related news, Director Uwe Roehrhoff purchased 7,500 shares of Catalent stock in a transaction that occurred on Tuesday, November 21st. The shares were acquired at an average cost of $39.22 per share, for a total transaction of $294,150.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.70% of the stock is owned by company insiders.
TRADEMARK VIOLATION NOTICE: This piece of content was originally posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.thelincolnianonline.com/2017/12/07/sg-americas-securities-llc-trims-stake-in-catalent-inc-ctlt-updated.html.
Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.
Receive News & Ratings for Catalent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.